Patents by Inventor Alison Paterson

Alison Paterson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIBODY MOLECULES TO CD73 AND USES THEREOF
    Publication number: 20230039109
    Abstract: Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
    Type: Application
    Filed: March 15, 2022
    Publication date: February 9, 2023
    Inventors: Bianka Prinz, Jerry M. Thomas, Ansgar Brock, Viviana Cremasco, Catherine Anne Sabatos-Peyton, Glenn Dranoff, Scott Chappel, Andrew Lake, Alison Paterson, Rachel W. O'Connor, Michael Warren, Pamela Holland, Kulandayan Kasi Subramanian, Helena Marie-Louise Fjaellskog, Dirksen Bussiere, Mikias Woldegiorgis, Wei Shu, John Delmas Venable, III, Michael Gladstone, Jonathan Hill, Christine Miller
  • Antibody molecules to CD73 and uses thereof
    Patent number: 11312783
    Abstract: Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
    Type: Grant
    Filed: June 21, 2018
    Date of Patent: April 26, 2022
    Assignees: Novartis AG, SURFACE ONCOLOGY, INC.
    Inventors: Bianka Prinz, Jerry M. Thomas, Ansgar Brock, Scott Chappel, Andrew Lake, Alison Paterson, Rachel W. O'Connor, Michael Warren, Pamela Holland, Dirksen Bussiere, Mikias Woldegiorgis, Wei Shu, John Delmas Venable, Michael Gladstone, Jonathan Hill, Christine Miller
  • ANTIBODY MOLECULES TO CD73 AND USES THEREOF
    Publication number: 20210214459
    Abstract: Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
    Type: Application
    Filed: May 30, 2019
    Publication date: July 15, 2021
    Inventors: Ansgar Brock, Viviana Cremasco, Catherine Anne Sabatos-Peyton, Glenn Dranoff, Kulandayan Kasi Subramanian, Marie-Louise Fjaellskog, John Delmas Venable, III, Bianka Prinz, Jerry M. Thomas, Andrew Lake, Scott Chappel, Pamela Holland, Michael Warren, Alison Paterson, Rachel W. O'Connor, Michael Gladstone, Jonathan Hill, Christine Miller
  • ANTI-CD47 ANTIBODIES AND METHODS OF USE
    Publication number: 20200291114
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Application
    Filed: January 16, 2020
    Publication date: September 17, 2020
    Inventors: Frank GROSVELD, Scott CHAPPEL, Jonathan HILL, Pamela M. HOLLAND, Andrew LAKE, Alison PATERSON
  • Anti-CD47 antibodies and methods of use
    Patent number: 10570201
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: February 25, 2020
    Assignees: Erasmus University Medical Center, Surface Oncology, Inc.
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • Anti-CD47 antibodies and methods of use
    Patent number: 10442858
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Grant
    Filed: September 21, 2017
    Date of Patent: October 15, 2019
    Assignees: Erasmus University Medical Center, Surface Oncology, Inc.
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • COMBINATION OF ANTI-CD47 ANTIBODIES AND CELL DEATH-INDUCING AGENTS, AND USES THEREOF
    Publication number: 20190062428
    Abstract: The present disclosure relates to combinations of anti-CD47 antibodies and cell death-inducing agents. The disclosure also relates to methods for treating or ameliorating one or more symptoms of a disease, such as cancer, by administering the combination.
    Type: Application
    Filed: June 19, 2018
    Publication date: February 28, 2019
    Inventors: Alison PATERSON, Marisa O. PELUSO, Vito PALOMBELLA, Ammar E. ADAM
  • ANTIBODY MOLECULES TO CD73 AND USES THEREOF
    Publication number: 20190031766
    Abstract: Antibody molecules that bind to CD73 are disclosed. The anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.
    Type: Application
    Filed: June 21, 2018
    Publication date: January 31, 2019
    Inventors: Bianka Prinz, Jerry M. Thomas, Ansgar Brock, Viviana Cremasco, Catherine Anne Sabatos-Peyton, Glenn Dranoff, Scott Chapel, Andrew Lake, Alison Paterson, Rachel W. O'Connor, Michael Warren, Pamela Holland, Kulandayan Kasi Subramanian, Marie-Louise Fjaellskog, Dirksen Bussiere, Mikias Woldegiorgis, Wei Shu, John Delmas Venable III
  • ANTI-CD47 ANTIBODIES AND METHODS OF USE
    Publication number: 20180201677
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Application
    Filed: September 21, 2017
    Publication date: July 19, 2018
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • ANTI-CD47 ANTIBODIES AND METHODS OF USE
    Publication number: 20180105591
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Application
    Filed: September 21, 2017
    Publication date: April 19, 2018
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • Anti-CD47 antibodies and methods of use
    Patent number: 9803016
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Grant
    Filed: March 29, 2017
    Date of Patent: October 31, 2017
    Assignees: Erasmus University Medical Center, Surface Oncology, Inc.
    Inventors: Frank Grosveld, Scott Chappel, Jonathan Hill, Pamela M. Holland, Andrew Lake, Alison Paterson
  • Anti-CD47 antibodies and methods of use
    Patent number: 9650441
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: May 16, 2017
    Assignees: Erasmus University Medical Center, Surface Oncology, Inc.
    Inventors: Frank Grosveld, Vito Palombella, Pamela M. Holland, Alison Paterson, Jonathan Hill
  • ANTI-CD47 ANTIBODIES AND METHODS OF USE
    Publication number: 20170081407
    Abstract: Disclosed herein are anti-CD47 antibody molecules, their manufacture and use in treating disorders associated with CD47 expression, for example, certain hematological cancers and solid tumors.
    Type: Application
    Filed: September 21, 2016
    Publication date: March 23, 2017
    Inventors: Frank Grosveld, Vito Palombella, Pamela M. Holland, Alison Paterson, Jonathan Hill